Whilst discounted cards might help relieve the burden of substantial drug charges from the short-term, they do not handle the systemic problems driving up prescription costs within the U.S. Broader plan changes could tackle the root will cause of climbing drug price ranges, for example lack of transparency in pricing and the role of intermediaries